out-of-pocket costs

Seven Ways to Help Patients Access Costly Cancer DrugsTwo new studies reveal that cost-restraints can keep patients from accessing life-preserving cancer drugs.
Is there a simple fix for the Part D discount program?A poll from the Biosimilars Council, a division of the Association for Accessible Medicines, has interesting findings about placing biosimilars and branded biologics on a level playing field to save money.
Opinion: Cost transparency improves collections and boosts satisfactionConsider providing cost estimates prior to rendering care to increase collections, patient satisfaction.
Aggressive price growth pushes healthcare spending upRise in use of outpatient care and professional services contributed to quicker growth in spending for the privately insured over previous years.
Four ways Medicare Part D has affected costs for diabetic patientsUnderstand Medicare Part D’s design and its coverage gap to offer the most affordable prescription drug options for patients.
Top 10 states with the highest uninsured ratesA new report highlights the highest uninsured rates by state. Is your state among the top 10?
Copay assistance programs: Managed care pros and consDo copay assistance program offer a long-term solution for patients? Experts weigh in.
Don't overlook vaccines in value-based benefit designA new study highlights why vaccination costs should be a top consideration when evaluating benefit offerings.
Drug spending rising at slower pacePBM Express Scripts shares findings from its new Drug Trend Report.
Antidepressant drug coverage may require special handlingA new Urban Institute study looks at the availability of antidepressants in marketplace insurance plans.